EFFECTS OF ABATACEPT on the Progression to Rheumatoid Arthritis(PALABA Study)
Status:
Not yet recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to test the hypothesis that abatacept can reduce the
progression of rheumatoid arthritis in ACPA+ or RF+ patients with palindromic rheumatism
compared with patients treated with hydroxychloroquine.